Company profile: Neem Biotech
1.1 - Company Overview
Company description
- Provider of biotechnology services specializing in pilot- to industrial-scale extraction of bio-active compounds from plant and marine sources to high-purity levels. Based in Cardiff, United Kingdom; incorporated in 1998 and, since July 20, 2012, operating as a subsidiary of InQpharm Group.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Neem Biotech
Albert Labs
HQ: Canada
Website
- Description: Provider of pharmaceutical drug development services focused on mental health, pursuing regulatory approval for active compounds. Offerings include KRN-101, a natural psilocybin medicine for cancer-related anxiety; psychedelic-assisted therapy training for mental health professionals; and real-world evidence studies to accelerate development and access of mental health medicines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Albert Labs company profile →
Eureka Genomics
HQ: United States
Website
- Description: Provider of Next Generation Sequencing and gene annotation services and diagnostics to detect inherited genetic traits, cancers, and infectious diseases in humans, animals, and crops. Offerings include detection of foreign nucleic acids, sequence data analysis, resequencing and mapping, platform-agnostic genotyping of SNPs, InDels, CNV, methylation, barley and bovine SNP panels, custom NGG assay design, and NGS for CE sequencing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eureka Genomics company profile →
PharmaTher
HQ: Canada
Website
- Description: Provider of ketamine-based medicines, developing KETARX (ketamine HCl injection) for anesthesia and procedural sedation via FDA ANDA; a hydrogel microneedle ketamine patch for neuropsychiatric, neurodegenerative and pain disorders; and PD-001, an oral enteric-coated cepharanthine for responsive cancers and infectious diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PharmaTher company profile →
Consensus
HQ: United States
Website
- Description: Provider of an AI-powered search engine that finds answers in scientific research, enabling discovery and consumption of the world's expert knowledge.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Consensus company profile →
Academia.edu
HQ: United States
Website
- Description: Provider of the largest and fastest-growing platform for sharing academic research, enabling academics to share research papers and aiming to accelerate and democratize academic research. Over 150 million academics have signed up, adding 25 million papers, with more than 100,000 people joining each day.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Academia.edu company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Neem Biotech
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Neem Biotech
2.2 - Growth funds investing in similar companies to Neem Biotech
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Neem Biotech
4.2 - Public trading comparable groups for Neem Biotech
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →